Dr. Bjorkman is the David Baltimore Professor of Biology and Biological Engineering and a Merkin Institute Professor at Caltech in Pasadena, California, USA. She received a B.A. in Chemistry from the University of Oregon and a Ph.D. in Biochemistry from Harvard University. As a graduate student and postdoctoral fellow in Don Wiley's laboratory, she solved the first crystal structure of a human histocompatibility complex molecule. She continued her postdoctoral training at Stanford with Mark Davis, where she worked on T cell receptors. At her Caltech laboratory, Dr. Bjorkman’s laboratory investigates the structural correlates of broad and potent antibody-mediated neutralization of HIV-1 and SARS-CoV-2 to inform vaccine design. In related work, they use 3D imaging techniques such as electron tomography to investigate HIV/SIV or SARS-CoV-2 infection in tissues and cells.
4 x speaker presentations, 15 minutes each:
1. Overview of broadly protective vaccines for pandemic prevention: A CIDRAP representative on: 1) the limitations of exclusively reactive vaccine development, 2) the value of defining explicit public health use cases to inform vaccine development, and 3) a brief overview of the various use cases applicable to vaccines for pandemic prevention. 2. Vaccine development and preparedness: A CEPI representative (e.g., Nadia Cohen, Adam Hacker, Mandeep Singh Dhingra) on broadly protective vaccines and how the various use cases can complement CEPI’s 100 Days Mission.3. Broadly protective vaccine feasibility: Florian Krammer, Rebecca Cox, Pamela Bjorkman, or a comparable virologist on what degree of breadth and protection is technically achievable vs. what is needed, using influenza and/or coronavirus vaccines as examples.4. Epidemiology, modeling, and deployment: Charles Whittaker, Asra Ghani, Ros Hollingsworth, Jane True, Lin-Fa Wang, or a comparable expert on when vaccination could prevent spillover, outbreak growth, transmission, and severe disease, as well as the potential impact of vaccine hesitancy, especially as it relates to MRNA platforms.
Additionally Proposed Speakers:CIDRAP RepresentativeCEPI Representative - Nadia Cohen, Adam Hacker, Mandeep Singh DhingraVirologist - Florian Krammer, Rebecca Cox, Pamela Bjorkman